KUALA LUMPUR, Malaysia, May 11 (IPS) – Thanks to President Biden, the US now supports a suspension of intellectual property (IP) rights to increase vaccine supplies. However, without vaccine developers sharing tacit technical knowledge for safe vaccine mass production, it will be difficult to rapidly scale up vaccine output.
Read the full story, “US Support for Vaccine Waiver Welcome, but More Needed”, on globalissues.org →